tbc-11251 has been researched along with Sensitivity and Specificity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahmany, S; Danser, AHJ; Hitzerd, E; Koch, BCP; van de Velde, D; van Domburg, B; Versmissen, J | 1 |
| Dinh-Xuan, AT; Hoeper, MM | 1 |
2 other study(ies) available for tbc-11251 and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous quantification of ambrisentan, macitentan and sitaxentan in human plasma using UPLC-MS/MS.
Topics: Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Isoxazoles; Linear Models; Phenylpropionates; Pyridazines; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Tandem Mass Spectrometry; Thiophenes | 2020 |
Pulmonary hypertension: basic concepts and practical management.
Topics: Bosentan; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Receptors, Endothelin; Sensitivity and Specificity; Sulfonamides; Survival Analysis; Thiophenes; Treatment Outcome | 2008 |